Carlsbad, CA, Zurich, Switzerland and Vienna, Austria – October 9, 2009: With partnering deals still driving drug development markets, this year’s BIO-Europe conference is set to establish new standards for generating quality partnering meetings and providing the insights needed to successfully operate in an era of dramatic biotech industry change. Many of the most respected industry thought leaders and decision makers will once again travel to BIO-Europe to examine the issues, new business approaches and policy trends that are vital to biotech’s successful long term future. To date, there are already 2,002 licensing opportunities, an impressive 1,170 companies from 46 countries registered, and over 2,000 delegates actively booking one-to-one meetings.

In a year in which the biotech sector has gone through dramatic changes, a central theme to BIO-Europe 2009 is addressing the challenge of how to maintain the innovation levels necessary to drive future revenue streams. Traditional business models in biotech are heavily reliant on venture funding, but the 2008–2009 financial crisis may have inflicted a potentially mortal wound to this model. The need for new, non-traditional sources of funding is being felt by biotechs the world over.

In the opening plenary session, “Rethinking the Drug Development Business Model”, Denise Pollard-Knight, PhD – CEO, Nomura Phase4 Ventures will lead a distinguished panel featuring Hakan Bjorklund, PhD – CEO, Nycomed; Arlene Morris – President and CEO, Affymax; Ian Nicholson, MBA – CEO, Chroma Therapeutics; and Dan Zabrowski – PhD, Global Head of Pharma Partnering, F. Hoffmann-La Roche Ltd. who will share their insights on the metamorphosis of the life science industry. They will discuss the impact these developments will have on their business strategies, and investigate whether there are new and more sustainable ways of funding drug development on the horizon

Notes to Editors:
Entry to BIO-Europe 2009 is free to members of the press, including full access to the partnering system, sessions, press conferences, workshops, and pre-arranged partnering meetings. Visit the BIO-Europe conference website at http://www.ebdgroup.com/bioeurope for detailed information on this year’s conference and online registration. When you register online, please indicate in the comment field that you are requesting a complimentary press registration: http://www.ebdgroup.com/bioeurope/press_reg.htm.

About BIO-Europe
BIO-Europe is the preeminent stand-alone partnering event for the biotechnology industry. Delegates from all parts of the biotechnology value-chain come to BIO-Europe to efficiently identify, engage and enter into the strategic relationships that drive their business successfully forward. The annual BIO-Europe partnering event draws over 2,500 industry attendees from almost 50 countries, representing more than 1,350 companies for three days of high level networking. BIO-Europe is organized by EBD Group with the support of the Biotechnology Industry Organization. For more information please visit http://www.ebdgroup.com/bioeurope

About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success. EBD Group’s conferences are run with the support of leading corporations and international trade associations, and include:

• BIO-Europe and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
• ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
• BioPharm America™, the fastest growing partnering event in North America
• Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
• EuroMedtech™, EBD Group’s new partnering event for the innovative medical technology industry
• BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO

EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world.
Outside of the conference format, EBD Group’s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.

EBD Group has offices in the USA and Europe.

For more information visit www.ebdgroup.com.

 

Contact:
Constantine Theodoropulos
EBD Group
+1 617 292 7319
ctheodoropulos@ebdgroup.com

Back to news